Skip to main content
OpenTrials

Clinical trial condition

Medulloblastoma

Explore clinical trials studying Medulloblastoma. Study availability and eligibility vary by location and protocol.

250 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Medulloblastoma trial results

Completed

A Study of Pemetrexed in Children With Recurrent Cancer

NCT00520936

Conditions
Ependymoma, Glioma, Medulloblastoma, +24 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arcadia, California, United States
View Trial Details
Completed

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

NCT00047177

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Familial ependymoma, +15 more
Locations
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

NCT00015899

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +31 more
Locations
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

NCT00006246

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +57 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Suspended

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

NCT06639607

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +24 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions